calendar
23,520 catalysts · 5,000 device 510k · 4,728 grant · 3,915 approval · 3,086 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
23,520 catalysts · 5,000 device 510k · 4,728 grant · 3,915 approval · 3,086 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: IPCA LABS LTD. Form: TABLET. Route: ORAL
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: LOXO ONCOL. Form: TABLET. Route: ORAL
Sponsor: ASTRAZENECA. Form: TABLET. Route: ORAL
Sponsor: ASTRAZENECA. Form: CAPSULE. Route: ORAL
Sponsor: PFIZER. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: PHARMACIA AND UPJOHN. Form: INJECTABLE. Route: INJECTION
Sponsor: GERON. Form: POWDER. Route: INTRAVENOUS
Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDS INC. Form: TABLET. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: SANDOZ INC. Form: FOR SUSPENSION. Route: ORAL
Sponsor: BAXTER HLTHCARE CORP. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL
Sponsor: LEO PHARMA AS. Form: INJECTABLE. Route: INJECTION
Sponsor: ELI LILLY AND CO. Form: CAPSULE. Route: ORAL
Sponsor: ELI LILLY AND CO. Form: CAPSULE. Route: ORAL
Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION
Sponsor: ALKEM LABS LTD. Form: CAPSULE. Route: ORAL
Sponsor: COLLEGIUM PHARM INC. Form: TABLET. Route: ORAL
Sponsor: COLLEGIUM PHARM INC. Form: SOLUTION. Route: ORAL
Sponsor: COLLEGIUM PHARM INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: UCB INC. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: ASTRAZENECA UK LTD. Form: INJECTABLE. Route: INJECTION
Sponsor: AMGEN. Form: INJECTABLE. Route: INJECTION
Sponsor: PYROS PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: AZURITY. Form: INJECTABLE. Route: INJECTION
Sponsor: BRISTOL. Form: TABLET. Route: ORAL
Sponsor: ARGENX BV. Form: INJECTABLE. Route: INJECTION
Sponsor: ARGENX BV. Form: INJECTABLE. Route: INJECTION
Sponsor: HARMONY. Form: TABLET. Route: ORAL
Sponsor: DAIICHI SANKYO INC. Form: TABLET. Route: ORAL
Sponsor: SHORLA. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: GENMAB US, INC.. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: AMNEAL PHARMS NY. Form: CAPSULE. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: ALVOTECH USA INC. Form: INJECTABLE. Route: INJECTION
Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: INTRAVENOUS